keyword
https://read.qxmd.com/read/38643469/aat-resistance-related-ac007405-2-and-al354989-1-as-novel-diagnostic-and-prognostic-markers-in-prostate-cancer
#1
JOURNAL ARTICLE
Yuanzhong Deng, Chunlin Zhang, Haitao Yu, Guo Chen, Xiang Peng, Yang Li, Zhenwei Feng, Wei Shi, Xuesong Bai, Xin Gou, Nian Liu
OBJECTIVE: Prostate cancer (PCa) is the second disease threatening men's health, and anti-androgen therapy (AAT) is a primary approach for treating this condition. Increasing evidence suggests that long non-coding RNAs (lncRNAs) play crucial roles in the development of PCa and the process of AAT resistance. The objective of this study is to utilize bioinformatics methods to excavate lncRNAs association with AAT resistance and investigate their biological functions. METHODS: AAT resistance-related risk score model (ARR-RSM) was established by multivariate Cox analysis...
April 19, 2024: Aging
https://read.qxmd.com/read/38643440/protein-intake-and-cancer-an-umbrella-review-of-systematic-reviews-for-the-evidence-based-guideline-of-the-german-nutrition-society
#2
REVIEW
Tilman Kühn, Nicole Kalotai, Anna M Amini, Julia Haardt, Andreas Lehmann, Annemarie Schmidt, Anette E Buyken, Sarah Egert, Sabine Ellinger, Anja Kroke, Stefan Lorkowski, Sandrine Louis, Matthias B Schulze, Lukas Schwingshackl, Roswitha Siener, Gabriele I Stangl, Bernhard Watzl, Armin Zittermann, Katharina Nimptsch
PURPOSE: It has been proposed that a higher habitual protein intake may increase cancer risk, possibly via upregulated insulin-like growth factor signalling. Since a systematic evaluation of human studies on protein intake and cancer risk based on a standardised assessment of systematic reviews (SRs) is lacking, we carried out an umbrella review of SRs on protein intake in relation to risks of different types of cancer. METHODS: Following a pre-specified protocol (PROSPERO: CRD42018082395), we retrieved SRs on protein intake and cancer risk published before January 22th 2024, and assessed the methodological quality and outcome-specific certainty of the evidence using a modified version of AMSTAR 2 and NutriGrade, respectively...
April 21, 2024: European Journal of Nutrition
https://read.qxmd.com/read/38643347/single-port-robot-assisted-radical-prostatectomy
#3
JOURNAL ARTICLE
Nicolas A Soputro, Jihad Kaouk
PURPOSE: To provide a comprehensive update on the different techniques and outcomes of contemporary Single-Port (SP) Robotic Radical Prostatectomy (RARP) approaches. METHODS: A literature review was performed to identify cohort studies that have utilized the purpose-built SP robotic platform (Intuitive Surgical Inc., Sunnyvale, California) for RARP. All published approaches of SP-RARP were included in our review. Baseline clinical, perioperative, and postoperative oncological and functional outcomes were collected from the included studies...
April 20, 2024: World Journal of Urology
https://read.qxmd.com/read/38643316/a-ten-year-experience-of-men-s-health-events-in-a-socioeconomically-diverse-city-in-the-united-states-lessons-learned
#4
JOURNAL ARTICLE
Shane Tinsley, Navid Mahabadi, Lauren Hamel, Gregory Dyson, Michael Lutz, Andrea Hamilton, Isaac Powell, Elisabeth I Heath
Community-based health events provide an opportunity to increase knowledge, awareness, and screening for acute and chronic diseases among individuals living in a socioeconomically diverse community. Because there are limited reports of such events, here we describe our ten-year experience of annual men's health fairs. This retrospective study of the Michigan Institute of Urology Foundation evaluated Men's Health Events held in Detroit, Michigan, from 2012 to 2021. Over 10 years, 11,129 men were screened and > 100,000 screenings were performed...
April 20, 2024: Journal of Community Health
https://read.qxmd.com/read/38643311/pharmacokinetic-study-of-capivasertib-and-the-cyp3a4-substrate-midazolam-in-patients-with-advanced-solid-tumors
#5
JOURNAL ARTICLE
Claire Miller, Roberto Sommavilla, Cindy L O'Bryant, Minal Barve, Afshin Dowlati, Jason J Luke, Mahmuda Khatun, Thomas Morris, Marie Cullberg
PURPOSE: Capivasertib, a potent, selective inhibitor of all three AKT serine/threonine kinase (AKT) isoforms, is being evaluated in phase 3 trials in advanced breast and prostate cancer. This study evaluated the drug-drug interaction risk of capivasertib with the cytochrome P450 3A substrate midazolam in previously treated adults with advanced solid tumors. METHODS: Patients received oral capivasertib 400 mg twice daily (BID) on an intermittent schedule (4 days on/3 days off) starting on day 2 of cycle 1 (29 days) and on day 1 of each 28-day cycle thereafter...
April 20, 2024: Cancer Chemotherapy and Pharmacology
https://read.qxmd.com/read/38643308/correction-a-multidisciplinary-approach-to-address-unmet-needs-in-the-management-of-patients-with-non-metastatic-castration-resistant-prostate-cancer
#6
Neal D Shore, Emmanuel S Antonarakis, Ashley E Ross, Catherine H Marshall, Kelly L Stratton, Adanma Ayanambakkam, Michael S Cookson, Rana R McKay, Alan H Bryce, Marina D Kaymakcalan
No abstract text is available yet for this article.
April 20, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38643307/prostatectomy-in-oligometastatic-prostate-cancer-a-call-for-high-quality-evidence
#7
REVIEW
Tanya Dorff, Sheetal R Kashid, Vedang Murthy, Riccardo Lombardo, Cosimo De Nunzio
The systematic review by Saouli et al. investigates the role of radical prostatectomy (RP) in managing oligometastatic prostate cancer (omPCa) [1]. They analyzed the existing literature to assess the oncological and functional outcomes of RP for these patients. RP is feasible and has an acceptable risk of complications. However, the lack of consensus on the definitions of omPCa and the low-quality evidence of the available comparative and retrospective studies, RP in omPCa should not be recommended outside of clinical trials...
April 20, 2024: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/38643291/fastmri-prostate-a-public-biparametric-mri-dataset-to-advance-machine-learning-for-prostate-cancer-imaging
#8
JOURNAL ARTICLE
Radhika Tibrewala, Tarun Dutt, Angela Tong, Luke Ginocchio, Riccardo Lattanzi, Mahesh B Keerthivasan, Steven H Baete, Sumit Chopra, Yvonne W Lui, Daniel K Sodickson, Hersh Chandarana, Patricia M Johnson
Magnetic resonance imaging (MRI) has experienced remarkable advancements in the integration of artificial intelligence (AI) for image acquisition and reconstruction. The availability of raw k-space data is crucial for training AI models in such tasks, but public MRI datasets are mostly restricted to DICOM images only. To address this limitation, the fastMRI initiative released brain and knee k-space datasets, which have since seen vigorous use. In May 2023, fastMRI was expanded to include biparametric (T2- and diffusion-weighted) prostate MRI data from a clinical population...
April 20, 2024: Scientific Data
https://read.qxmd.com/read/38643250/evaluation-of-the-learning-curve-for-thulium-laser-enucleation-of-the-prostate-in-a-contemporary-cohort
#9
JOURNAL ARTICLE
D Perri, A Pacchetti, E Morini, U Besana, F Mazzoleni, E Verzotti, M Maltagliati, J Romero-Otero, A L Pastore, P Broggini, B Rocco, A S Gozen, P Kallidonis, G Bozzini
PURPOSE: To assess the learning curve of Thulium laser enucleation of the prostate (ThuLEP) of a single surgeon. METHODS: Hundred patients suffering from benign prostatic hyperplasia were treated by the same surgeon. In all cases, a well-trained urologist was present in the operating room. Patients urinary function was assessed preoperatively using the International Prostate Symptoms Score (IPSS), maximum flow rate and Post-Void Residual volume. Preoperative prostate volume was recorded...
April 20, 2024: World Journal of Urology
https://read.qxmd.com/read/38643190/endoplasmic-reticulum-stress-related-genes-as-prognostic-and-immunogenic-biomarkers-in-prostate-cancer
#10
JOURNAL ARTICLE
Lilin Wan, Yunxia Fan, Tiange Wu, Yifan Liu, Ruixin Zhang, Saisai Chen, Chenggui Zhao, Yifeng Xue
BACKGROUND: The metastasis and aggressive nature of prostate cancer (PCa) has become a major malignancy related threat that concerns men's health. The efficacy of immune monotherapy against PCa is questionable due to its lymphocyte-suppressive nature. METHOD: Endoplasmic reticulum stress- (ERS-) and PCa-prognosis-related genes were obtained from the Molecular Signatures Database and the Cancer Genome Atlas database. The expression, prognosis and immune infiltration values of key genes were explored by "survival R package", "rms", "xCELL algorithm", and univariate-multivariate Cox and LASSO regression analyses...
April 20, 2024: European Journal of Medical Research
https://read.qxmd.com/read/38643097/the-effects-of-different-positions-on-lower-extremity-hemodynamics-during-robot-assisted-laparoscopic-radical-prostatectomy-for-prostate-cancer
#11
JOURNAL ARTICLE
Zheng Wang, Xinyu Wang, Xiaofen Yu
PURPOSE: This study aimed to investigate the effects of two different positions on lower extremity hemodynamics during robot-assisted laparoscopic radical prostatectomy (RARP) for prostate cancer. METHODS: A total of 196 patients who underwent RARP in our hospital from February 2020 to March 2022 were included in this study. Among them, 98 patients who underwent surgery with the Trendelenburg position and split-leg position with calf reverse arch from March 2021 to March 2022 were assigned to the observation group, while 98 patients who underwent surgery with the Trendelenburg position and low lithotomy position from February 2020 to February 2021 were assigned to the control group...
April 20, 2024: BMC Urology
https://read.qxmd.com/read/38643096/mendelian-randomization-study-supports-positive-bidirectional-causal-relationships-between-genetically-predicted-insomnia-symptom-and-liability-to-benign-prostatic-hyperplasia
#12
JOURNAL ARTICLE
Nannan Li, Ke Yang, Liang Deng, Youjie Zeng, Si Cao, Dong Chen
BACKGROUND: Sleep quality may be related to benign prostatic hyperplasia (BPH), however causal associations have not been established. This study aimed to evaluate causal relationships between six sleep traits ([i] day time napping, [ii] daytime sleepiness, [iii] insomnia, [iv] long sleep duration, [v] short sleep duration, and [vi] sleep duration per hour) and BPH through a bidirectional Mendelian randomization (MR) study. METHODS: Genome-wide association summary statistics of sleep traits and BPH were downloaded from public databases...
April 20, 2024: BMC Urology
https://read.qxmd.com/read/38643022/avoiding-needless-nephrectomy-what-is-the-role-of-small-renal-mass-biopsy-in-2024
#13
REVIEW
Bruce Gao, Antonio R H Gorgen, Rohit Bhatt, Zachary E Tano, Kalon L Morgan, Kelvin Vo, Sina Soltanzadeh Zarandi, Sohrab N Ali, Pengbo Jiang, Roshan M Patel, Ralph V Clayman, Jaime Landman
Current guidelines do not mandate routine preoperative renal mass biopsy (RMB) for small renal masses (SRMs), which results in a considerable rate (18%-26%) of needless nephrectomy/partial nephrectomy for benign renal tumors. In light of this ongoing practice, a narrative review was conducted to examine the role of routine RMB for SRM. First, arguments justifying the current non-biopsy approach to SRM are critically reviewed and contested. Second, as a standalone procedure, RMB is critically assessed; RMB was found to have higher sensitivity, specificity, and an equal or lower complication rate when compared with other commonly preoperatively biopsied solid organ tumors (e...
April 19, 2024: Urologic Oncology
https://read.qxmd.com/read/38642466/holmium-laser-enucleation-of-the-prostate-for-a-case-of-transition-zone-prostate-cancer
#14
JOURNAL ARTICLE
Michelle K Li, Orlando Diaz, Jonathan E Katz
Standard treatment approaches for localized prostate cancer remain limited to active surveillance, radiotherapy, and radical prostatectomy. We present a case of transition zone prostate cancer that was treated with holmium laser enucleation of the prostate, a procedure that is normally reserved for the management of benign prostatic hyperplasia.
April 2024: Canadian Journal of Urology
https://read.qxmd.com/read/38642463/how-i-do-it-teaching-holmium-laser-enucleation-of-the-prostate-holep
#15
JOURNAL ARTICLE
Agustín Pérez-Londoño, Alejandro Abello, Boris Gershman, Ruslan Korets
Holmium laser enucleation of the prostate (HoLEP) is considered a size-independent technique to treat benign prostatic hyperplasia. This safe and effective procedure is increasingly being adopted in urology training programs worldwide, yet limited teaching strategies have been described. Endoscopic handling during HoLEP allows for a simultaneous interaction between the surgeon and trainee, facilitating a guided teaching strategy with increasing difficulty as experience grows. In this article, we describe our stepwise approach for teaching HoLEP as part of a structured surgical training curriculum...
April 2024: Canadian Journal of Urology
https://read.qxmd.com/read/38642459/optimizing-outcomes-in-men-with-prostate-cancer-the-cardiovascular-event-lowering-caelo-pathways
#16
JOURNAL ARTICLE
David E Crawford, David Albala, Marc B Garnick, Andrew W Hahn, Paul Maroni, Rana R McKay, Martin Miner, Peter Orio Ⅲ, Kshitij Pandit, Scott Sellinger, Evan Y Yu, Robert H Eckel
INTRODUCTION: Risk of cardiovascular disease is higher among men with prostate cancer than men without, and prostate cancer treatments (especially those that are hormonally based) are associated with increased cardiovascular risk. MATERIALS AND METHODS: An 11-member panel of urologic, medical, and radiation oncologists (along with a men's health specialist and an endocrinologist/preventive cardiologist) met to discuss current practices and challenges in the management of cardiovascular risk in prostate cancer patients who are taking androgen deprivation therapies (ADT) including LHRH analogues, alone and in combination with androgen-targeted therapies (ATTs)...
April 2024: Canadian Journal of Urology
https://read.qxmd.com/read/38642457/is-psma-pet-disrupting-traditional-prostate-cancer-staging-and-treatment
#17
EDITORIAL
Leonard G Gomella
No abstract text is available yet for this article.
April 2024: Canadian Journal of Urology
https://read.qxmd.com/read/38642371/discovery-and-mechanistic-studies-of-dual-target-hits-for-carbonic-anhydrase-ix-and-vegfr-2-as-potential-agents-for-solid-tumors-x-ray-in-vitro-in-vivo-and-in-silico-investigations-of-coumarin-based-thiazoles
#18
JOURNAL ARTICLE
Salma M Hefny, Tarek F El-Moselhy, Nabaweya El-Din, Simone Giovannuzzi, Thamer Bin Traiki, Mansoor-Ali Vaali-Mohammed, Ahmed M El-Dessouki, Koki Yamaguchi, Masaharu Sugiura, Moataz A Shaldam, Claudiu T Supuran, Maha-Hamadien Abdulla, Wagdy M Eldehna, Haytham O Tawfik
A dual-targeting approach is predicted to yield better cancer therapy outcomes. Consequently, a series of coumarin-based thiazoles ( 5a - h , 6 , and 7a - e ) were designed and constructed as potential carbonic anhydrase (CA) and VEGFR-2 suppressors. The inhibitory actions of the target compounds were assessed against CA isoforms IX and VEGFR-2. The assay results showed that coumarin-based thiazoles 5a , 5d , and 5e can effectively inhibit both targets. 5a , 5d , and 5e cytotoxic effects were tested on pancreatic, breast, and prostate cancer cells (PANC1, MCF7, and PC3)...
April 20, 2024: Journal of Medicinal Chemistry
https://read.qxmd.com/read/38642309/assessment-of-structural-and-activity-related-contributions-of-various-pim-1-kinase-inhibitors-in-the-treatment-of-leukemia-and-prostate-cancer
#19
REVIEW
Anushka Sharma, Rahul Dubey, Vikas Asati, Gurkaran Singh Baweja, Shankar Gupta, Vivek Asati
One of the most perilous illnesses in the world is cancer. The cancer may be associated with the mutation of different genes inside the body. The PIM kinase, also known as the serine/threonine kinase, plays a critical role in the biology of different kinds of cancer. They are widely distributed and associated with several biological processes, including cell division, proliferation, and death. Aberration of PIM-1 kinase is found in varieties of cancer. Prostate cancer and leukemia can both be effectively treated with PIM-1 kinase inhibitors...
April 20, 2024: Molecular Diversity
https://read.qxmd.com/read/38642282/correction-to-surgical-management-and-considerations-for-patients-with-localized-high-risk-prostate-cancer
#20
Andrew M Fang, Jamaal Jackson, Justin R Gregg, Lisly Chery, Chad Tang, Devaki Shilpa Surasi, Bilal A Siddiqui, Soroush Rais-Bahrami, Tharakeswara Bathala, Brian F Chapin
No abstract text is available yet for this article.
April 20, 2024: Current Treatment Options in Oncology
keyword
keyword
407
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.